- 全部删除
您的购物车当前为空
Moxilubant HCl 是一种小分子白三烯 B4 受体 1(LTB4R)拮抗剂,可用于治疗免疫系统疾病、皮肤和肌肉骨骼疾病,可用于研究银屑病和类风湿关节炎。


为众多的药物研发团队赋能,
让新药发现更简单!
Moxilubant HCl 是一种小分子白三烯 B4 受体 1(LTB4R)拮抗剂,可用于治疗免疫系统疾病、皮肤和肌肉骨骼疾病,可用于研究银屑病和类风湿关节炎。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 546 | In stock | |
| 5 mg | ¥ 1,210 | In stock | |
| 10 mg | ¥ 1,790 | In stock | |
| 25 mg | ¥ 2,870 | In stock | |
| 50 mg | ¥ 4,090 | In stock | |
| 100 mg | ¥ 5,680 | In stock | |
| 200 mg | ¥ 7,630 | In stock |
Moxilubant HCl 相关产品
| 产品描述 | Moxilubant HCl is a small molecule leukotriene B4 receptor 1 (LTB4R) antagonist for the treatment of immune system disorders, skin and musculoskeletal disorders, and may be used in studies of psoriasis and rheumatoid arthritis. |
| 体外活性 | Moxilubant hcl 以2-4 nM 的潜力抑制 LTB4 信号传递。 |
| 体内活性 | Moxilubant hcl(口服;每天一至两次,每次100至500mg,连续7天)对LTB4途径的抑制作用在至少达到75%(150mg)时显著,当剂量增至300mg时,途径抑制作用可达到100%。[1] |
| 别名 | Moxilubant hcl(146978-48-5 Free base) |
| 分子量 | 492.05 |
| 分子式 | C26H38ClN3O4 |
| CAS No. | 146957-32-6 |
| Smiles | Cl.O=C(C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(=N)N)C(OC)=C1)N(C(C)C)C(C)C |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 50 mg/mL (101.62 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容